In:
Ophthalmic Plastic & Reconstructive Surgery, Ovid Technologies (Wolters Kluwer Health), Vol. 36, No. 5 ( 2020-09), p. 490-496
Abstract:
To determine the association of Fitzpatrick skin type (FST) with conjunctival melanoma. Methods: Retrospective case series of 540 patients with conjunctival melanoma to assess clinical features and outcomes per FST. Results: The FST was Type I (n = 126, 23%), II (n = 337, 62%), III (n = 56, 10%), IV (n = 8, 2%), V (n = 12, 2%), and VI (n = 1, 〈 1%). A comparison (FST I vs. II vs. III, IV, V, and VI) revealed Types I and II associated with older mean patient age (63.9 vs. 60.7 vs. 51.1 years, p 〈 0.001), greater percentage of female patients (68% vs. 44% vs. 42%, p 〈 0.001), lower frequency of complexion associated melanosis (1% vs. 2% vs. 13%, p 〈 0.001), smaller tumor thickness (2.1 vs. 2.8 vs. 3.6 mm, p = 0.01), and less eyelid involvement (13% vs. 13% vs. 28%, p = 0.02). Kaplan–Meier estimates for 5-year risk showed no difference by Types for visual acuity loss ≥3 lines, local tumor recurrence, exenteration, metastasis, or death. Conclusion and relevance: Most patients with conjunctival melanoma show FST I or II, and this demonstrated no association with 5-year rate of vision loss, tumor recurrence, exenteration, metastasis, or death.
Type of Medium:
Online Resource
ISSN:
0740-9303
DOI:
10.1097/IOP.0000000000001624
Language:
English
Publisher:
Ovid Technologies (Wolters Kluwer Health)
Publication Date:
2020
detail.hit.zdb_id:
2070654-6
Bookmarklink